CA1060438A - Compose pharmaceutique - Google Patents

Compose pharmaceutique

Info

Publication number
CA1060438A
CA1060438A CA225,873A CA225873A CA1060438A CA 1060438 A CA1060438 A CA 1060438A CA 225873 A CA225873 A CA 225873A CA 1060438 A CA1060438 A CA 1060438A
Authority
CA
Canada
Prior art keywords
group
hydrogen
formula
substituted
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA225,873A
Other languages
English (en)
Inventor
Alexander Lawson
Abdul F. Al-Sayyab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REPUBLIC OF IRAQ (GOVERNMENT OF THE) AS REPRESENTED BY MR ABDUL FATTAHZ ALT CHIEF OF BUREAU OF LEGAL AFFAIRS OF REVOLUTIONARY COMMAN
Original Assignee
REPUBLIC OF IRAQ (GOVERNMENT OF THE) AS REPRESENTED BY MR ABDUL FATTAHZ ALT CHIEF OF BUREAU OF LEGAL AFFAIRS OF REVOLUTIONARY COMMAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by REPUBLIC OF IRAQ (GOVERNMENT OF THE) AS REPRESENTED BY MR ABDUL FATTAHZ ALT CHIEF OF BUREAU OF LEGAL AFFAIRS OF REVOLUTIONARY COMMAN filed Critical REPUBLIC OF IRAQ (GOVERNMENT OF THE) AS REPRESENTED BY MR ABDUL FATTAHZ ALT CHIEF OF BUREAU OF LEGAL AFFAIRS OF REVOLUTIONARY COMMAN
Application granted granted Critical
Publication of CA1060438A publication Critical patent/CA1060438A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
CA225,873A 1974-05-01 1975-04-30 Compose pharmaceutique Expired CA1060438A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1915774A GB1529564A (en) 1974-05-01 1974-05-01 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CA1060438A true CA1060438A (fr) 1979-08-14

Family

ID=10124714

Family Applications (1)

Application Number Title Priority Date Filing Date
CA225,873A Expired CA1060438A (fr) 1974-05-01 1975-04-30 Compose pharmaceutique

Country Status (11)

Country Link
JP (1) JPS5112933A (fr)
AU (1) AU502579B2 (fr)
BE (1) BE828530A (fr)
CA (1) CA1060438A (fr)
DE (1) DE2519193A1 (fr)
EG (1) EG12028A (fr)
ES (1) ES437363A1 (fr)
FR (1) FR2282870A1 (fr)
GB (1) GB1529564A (fr)
NL (1) NL7505174A (fr)
NZ (1) NZ177384A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2418222A2 (fr) * 1975-08-01 1979-09-21 Synthelabo Procede de preparation de derives benzylideniques
JPS52159599U (fr) * 1976-05-27 1977-12-03
JPS5812993Y2 (ja) * 1978-07-19 1983-03-12 日本鋼管株式会社 吊下開閉式足場装置
FR2475543A1 (fr) * 1980-02-12 1981-08-14 Synthelabo Derives benzylideniques, leur preparation et leur application en therapeutique
FR2544308B1 (fr) * 1983-04-14 1985-06-14 Synthelabo Ethines substituees, leur preparation et leur application en therapeutique
NO940195L (no) * 1993-01-25 1994-07-26 Norsk Hydro As Nye forbindelser

Also Published As

Publication number Publication date
JPS5112933A (ja) 1976-01-31
NL7505174A (nl) 1975-11-04
FR2282870A1 (fr) 1976-03-26
AU502579B2 (en) 1979-08-02
EG12028A (en) 1978-06-30
DE2519193A1 (de) 1975-11-20
NZ177384A (en) 1978-03-06
GB1529564A (en) 1978-10-25
FR2282870B1 (fr) 1978-11-10
ES437363A1 (es) 1977-05-16
BE828530A (fr) 1975-10-29
AU8072175A (en) 1976-11-04

Similar Documents

Publication Publication Date Title
JP3020760B2 (ja) 水溶性カンプトテシン誘導体
FI61479C (fi) Foerfarande foer framstaellning av spasmolytiska nya d,l-tyrosinderivat
WO1992021661A1 (fr) Composes cycliques antitumoraux
CA1060438A (fr) Compose pharmaceutique
JPS62111962A (ja) ３−フエニルチオメチルスチレン誘導体
US20140371193A1 (en) Organometallic complexes as therapeutic agents
US4076843A (en) 5,6,7,8-Tetrahydronaphthalene hypotensive agents
US10759809B2 (en) Deuterated compound and medical use thereof
JP4001636B2 (ja) ガンおよびａｉｄｓの処置のための活性化ヨード誘導体
CA3039070A1 (fr) Inhibiteurs d'interactions mtor-deptor et leurs procedes d'utilisation
EP0767777B1 (fr) Nouveaux sels d'acide 2-[(2,6-dichlorophenyl)amine]phenylacetoxyacetique a cations basiques organiques
JPS588387B2 (ja) シンナムアミドノセイゾウホウホウ
CA1133913A (fr) N-(1-methyl-2-pyrrolidinyl-methyl)-2,3-dimethoxy-5- methylsulfamoyl benzamide et ses derives; leurs methodes de preparation, et leur utilisation dans le traitement de troubles de l'appareil urinaire inferieur
EP0045473B1 (fr) Composition pharmaceutique contenant comme principe actif un dérivé du benzofuranne carboxamide
US3742056A (en) Aromatic acet amidoxime-o-carbamates
US3635971A (en) 3 (3 4-dihydro-3-oxo-2-quinoxalinyl) propionamides
FR2846330A1 (fr) Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
JPS62108863A (ja) ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬
JPH0237357B2 (fr)
US4423236A (en) 5,6,-0-Isoalkylidene ascorbic acid derivatives
IL42949A (en) Pharmaceutical compositions containing indole n-acyl-3 (trichloroethyl) acetate
US3452141A (en) Methods of treating pain with n**alpha-phthaloyl-alpha-amino acid amides
US3377380A (en) Dibenzocycloheptenyl carboxyhydrazides
US5817680A (en) Hemoregulatory compounds
IE53190B1 (en) Esters of 2-thenoylmercaptopropionylglycine with substituted hydroxybenzenes,process for their preparation and pharmaceutical compositions containing same